Recently, detection of RAD51, a central HR protein, in immunostained formalin-fixed, paraffin-embedded (FFPE) sections without externally induced DNA damage has shown great promise in identifying HRD breast cancers (26–28). The gene discussed is RAD51; the disease is breast cancer.